These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34871054)

  • 1. In critically ill patients with COVID-19, therapeutic anticoagulation did not increase organ support-free days.
    Donato AA
    Ann Intern Med; 2021 Dec; 174(12):JC135. PubMed ID: 34871054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In non-critically ill patients with COVID-19, therapeutic anticoagulation improved survival to discharge without organ support.
    Donato AA
    Ann Intern Med; 2021 Dec; 174(12):JC134. PubMed ID: 34871053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
    Kreidieh F; Temraz S
    Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In patients hospitalized with COVID-19, therapeutic- vs. prophylactic-dose heparin did not reduce a composite outcome at 28 d.
    Bikdeli B; Garcia DA
    Ann Intern Med; 2022 Feb; 175(2):JC16. PubMed ID: 35099997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 in the Critically Ill: Too Risky for High-Dose Anticoagulation?
    Paez Vargas JJ; Vidal González A; Pérez-Calvo C; Flandes J
    Chest; 2021 Aug; 160(2):e249. PubMed ID: 34366058
    [No Abstract]   [Full Text] [Related]  

  • 6. In high-risk inpatients with COVID-19, therapeutic- vs. standard-dose heparin reduced thromboembolism or death at 30 d.
    Bikdeli B; Garcia DA
    Ann Intern Med; 2022 Feb; 175(2):JC17. PubMed ID: 35099994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
    Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
    Thromb Res; 2020 Dec; 196():313-317. PubMed ID: 32977129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Anticoagulation with Heparin in Patients with Covid-19. Reply.
    Zarychanski R; Lawler PR; Goligher E
    N Engl J Med; 2021 Nov; 385(21):2014. PubMed ID: 34788517
    [No Abstract]   [Full Text] [Related]  

  • 9. In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleeding.
    Chaudhuri D; Rochwerg B
    Ann Intern Med; 2022 Feb; 175(2):JC18. PubMed ID: 35099996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In critically ill patients with COVID-19, antiplatelet therapy did not increase organ support-free days at 21 d.
    Athale J; Danner RL
    Ann Intern Med; 2022 Jul; 175(7):JC80. PubMed ID: 35785539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on Hadadi et al., Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects? J. Med. Virol. 2020; 92:915-918.
    Gando A; Alexay S; Galán Núñez JP; Cano LN; Diez RA; Costa LA
    J Med Virol; 2021 May; 93(5):2626-2627. PubMed ID: 33590886
    [No Abstract]   [Full Text] [Related]  

  • 12. In uninfected household contacts of patients with COVID-19, REGEN-COV reduced symptomatic COVID-19 at 28 d.
    Lau D; Saxinger L
    Ann Intern Med; 2022 Jan; 175(1):JC5. PubMed ID: 34978854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empiric Therapeutic Anticoagulation and Mortality in Critically Ill Patients With Respiratory Failure From SARS-CoV-2: A Retrospective Cohort Study.
    Ferguson J; Volk S; Vondracek T; Flanigan J; Chernaik A
    J Clin Pharmacol; 2020 Nov; 60(11):1411-1415. PubMed ID: 32885463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuation of therapeutic dose heparin for critically ill patients with COVID-19.
    Bradbury CA; Lawler PR; McVerry BJ; Zarychanski R;
    Intensive Care Med; 2023 Jul; 49(7):873-875. PubMed ID: 37256341
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic Anticoagulation with Heparin in Patients with Covid-19.
    Sterpetti AV
    N Engl J Med; 2021 Nov; 385(21):2013-2014. PubMed ID: 34788516
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic Anticoagulation with Heparin in Patients with Covid-19.
    Fernandes TM; McGuire WC; Morris TA
    N Engl J Med; 2021 Nov; 385(21):2013. PubMed ID: 34788515
    [No Abstract]   [Full Text] [Related]  

  • 17. Best practice statements and recommendations for caring for critically ill patients with COVID-19.
    Dugar SP; Vallabhajosyula S
    Ann Intern Med; 2020 Jun; 172(12):JC62. PubMed ID: 32539521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dialysis circuit clotting in critically ill patients with COVID-19 infection.
    Khoo BZE; Lim RS; See YP; Yeo SC
    BMC Nephrol; 2021 Apr; 22(1):141. PubMed ID: 33879086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous Muscle Hematoma in Japanese Patients with Severe COVID-19 Treated with Unfractionated Heparin: Two Case Reports.
    Ito Y; Awano N; Uchiyama F; Inomata M; Kuse N; Tone M; Takada K; Fujimoto K; Muto Y; Sagisaka S; Maki K; Yamashita R; Harada A; Nishimura JI; Hayashi M; Izumo T
    Intern Med; 2021 Nov; 60(21):3503-3506. PubMed ID: 34433713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment.
    Roncon L; Zuin M; Rigatelli G
    Intern Emerg Med; 2021 Mar; 16(2):517-518. PubMed ID: 32378044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.